Tehran University of Medical Sciences

Science Communicator Platform

Share By
Cytokines and Covid-19: Friends or Foes? Publisher Pubmed



Rokni M1 ; Hamblin MR2, 3 ; Rezaei N1, 4, 5
Authors

Source: Human Vaccines and Immunotherapeutics Published:2020


Abstract

The cytokine storm following sepsis has been proven to be an important mechanism for triggering acute respiratory distress syndrome, which is a fatal uncontrolled systemic inflammation characterized by high concentrations of pro-inflammatory cytokines and chemokines, secreted by immune effector cells. The cytokine storm also occurs in the recently emerged novel coronavirus disease (COVID-19). Therefore, cytokines which usually help the immune system to fight infections are potentially harmful in the course of COVID-19 infections. Therefore, avoiding or mitigating the cytokine storm may be a key treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). © 2020 Taylor & Francis Group, LLC.
Related Docs
View other Related Docs
1. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
2. Covid-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions, Frontiers in Cell and Developmental Biology (2021)
3. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Babak Arjmand (2)
Other Related Docs
4. The Role of Cytokines and Their Antagonists in the Treatment of Covid-19 Patients, Reviews in Medical Virology (2023)
5. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)
6. Extracorporeal Hemoperfusion As a Potential Therapeutic Option for Severe Covid-19 Patients; a Narrative Review, Archives of Academic Emergency Medicine (2020)
7. Interindividual Immunogenic Variants: Susceptibility to Coronavirus, Respiratory Syncytial Virus and Influenza Virus, Reviews in Medical Virology (2021)
8. Proinflammatory and Immunomodulatory Cytokine Mrna Changes by Real-Time Rt-Pcr in Patients With Covid-19 Hospitalization in the Icu and People Recovering From the Disease, Minerva Pneumologica (2020)
9. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
10. Coronavirus Disease 2019 (Covid-19): Immune Responses, Transmission, and Clinical Features: An Update, Journal of Cellular and Molecular Anesthesia (2020)
11. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
12. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
13. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
14. An Overview of the Recent Findings of Cell-Based Therapies for the Treatment and Management of Covid-19, International Immunopharmacology (2021)
15. Selective Serotonin Reuptake Inhibitors: New Hope in the Fight Against Covid-19, Frontiers in Pharmacology (2022)
16. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
17. Current Evidence on the Use of Anakinra in Covid-19, International Immunopharmacology (2022)
18. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)
19. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)
20. The Role of Inflammation in the Development of Complications Caused by Covid-19: A Review Study, Journal of Payavard Salamat (2022)